What is this collection about?
Cardiometabolic diseases - including certain liver diseases, cardiovascular diseases and type 2 diabetes - arise from complex and interconnected metabolic, inflammatory and vascular processes. Increasing evidence shows that these conditions share common biological pathways and overlapping clinical features, reshaping how they are understood and managed and highlighting the need for integrated, cross-disciplinary approaches.
In this cross-journal Collection, editors from Nature Medicine, Nature Cardiovascular Research, Nature Communications, Communications Medicine, Communications Health and Scientific Reports invite submissions that advance understanding of cardiometabolic disease across both mechanistic and clinical domains. We welcome research investigating molecular and cellular pathways such as metabolic dysfunction, inflammation and vascular biology, alongside translational studies linking these mechanisms to disease progression and therapeutic response. Clinical studies evaluating interventions, including pharmacological and lifestyle approaches, as well as work on risk stratification and patient phenotyping, are encouraged. We particularly welcome submissions addressing multimorbidity and informing more precise and effective clinical management strategies.
Scientific Reports will consider original Articles whilst the other journals will consider Articles, Reviews and Perspectives.
Why is this collection important?
Cardiometabolic disease represents one of the most pressing global health challenges, contributing significantly to morbidity and mortality worldwide. The growing recognition that metabolic, inflammatory and vascular processes are deeply interconnected is transforming the field, creating new opportunities for more holistic and precise approaches to prevention, diagnosis and treatment.
This Collection is particularly exciting because it brings together a cross-journal perspective, spanning multiple disciplines and research communities. By integrating basic, translational and clinical research, it has the potential to accelerate discoveries that move beyond siloed approaches and lead to meaningful improvements in patient outcomes.
This Collection also aligns closely with the United Nations Sustainable Development Goal 3 (Good Health and Well-being), supporting research that aims to improve health outcomes across populations. Its broad scope and strong editorial backing make it an ideal platform for researchers looking to maximise the visibility and impact of their work in this rapidly evolving field.
Why submit to a collection?
Collections like this one help promote high-quality science. They are led by In-House Editors who are experts in their fields and supported by a dedicated team of Commissioning Editors and Managing Editors at Springer Nature. Collection manuscripts typically see higher citations, downloads, and Altmetric scores, and provide a one-stop-shop on a cutting-edge topic of interest.
Who is involved?
Communications Medicine is edited by both in-house professional editors and Editorial Board Members.
Nature Medicine is edited by in-house professional editors.
Nature Cardiovascular Research is edited by in-house professional editors.
Nature Communications is edited by in-house professional editors.
Communications Health is edited by both in-house professional editors and Editorial Board Members.
Scientific Reports is edited by both in-house professional editors and Editorial Board Members.
Our editors work closely together to ensure the quality of our published papers and consistency in author experience.
How can I submit my paper?
Visit the Collection page to find out more about this collection and submit your article.